What’s more, heart failure risk increases as hearing loss progresses, researchers found. The psychological distress caused by hearing loss plays a key role in this association, researchers added.

Heart failure (HF) is a complex and varied condition that affects over 50 million people worldwide. Although there have been significant strides in understanding the underlying mechanisms of HF, ...

Hearing impairment, psychological distress, and incident heart failure: a prospective cohort study, Heart (2025). DOI: 10.1136//heartjnl-2024-325394. Posted in: Medical Research News | Medical ...

Get Instant Summarized Text (Gist) An injectable hydrogel derived from fish swim bladders has been developed to repair damaged heart tissue. This hydrogel, composed of collagen, glycosaminoglycans ...

The cause of death is believed to be heart failure, the brewery’s representatives said. He was 46.” Lou Raguse at KARE 11 reports: “The University of Minnesota student who argues in a ...

New University of Bristol research on how healthcare professionals can support people with heart failure who want to be more physically active has been published in BMJ Open. The study recommends a ...

Allowing patients with heart failure to drink as much fluid as they want had no negative effects on safety outcomes — including hospitalization and death — and prevented discomfort related to ...

Department of Cardiology, Rigshospitalet, Copenhagen, Denmark (T.D., K.R., M.E., W.H.N., F.G.). Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty ...

Canada Study objectives Hospital admission rates for patients with heart failure (HF) presenting for emergency department (ED) care vary, and the implications of direct discharge home from the ED are ...

The following is a summary of “Evaluating the Real-World Use of Topical Diclofenac Sodium Gel 1% Using US Longitudinal Electronic Health Records Database: A study supporting OTC switch,” published in ...

Rexlemestrocel-L is being developed for heart failure and chronic low back pain. The Company has established commercial partnerships in Japan, Europe and China.

Limitations included missing patient-reported outcomes, exclusion of advanced heart failure patients, and COVID-19's impact on recruitment and care patterns. Despite showing no overall benefit ...